Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy
Kupiec-Weglinski, J.W.; Hahn, H.J.; Kirkman, R.L.; Volk, H.D.; Mouzaki, A.; DiStefano, R.; Tellides, G.; Dallman, M.; Morris, P.J.; Strom, T.B.
Transplantation Proceedings 20(2 Suppl 2): 207-216
1988
ISSN/ISBN: 0041-1345 PMID: 3129841 Document Number: 323524
Document emailed within 1 workday
Related Documents
Lord, R.H.; Hancock, W.W.; Colby, A.J.; Padberg, W.; Diamantstein, T.; Kupiec-Weglinski, J.W.; Tilney, N.L. 1987: Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat Transplantation Proceedings 19(1 Part 1): 354-355Cahn, J.Y.; Bordigoni, P.; Tiberghien, P.; Milpied, N.; Brion, A.; Widjenes, J.; Lioure, B.; Michel, G.; Burdach, S.; Kolb, H.J. 1995: Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. a multicenter phase IIi study Transplantation 60(9): 939-942
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639
Bemelmans, M.H.; Abramowicz, D.; Gouma, D.J.; Goldman, M.; Buurman, W.A. 1994: In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies Journal of Immunology 153(2): 499-506
Wissing, K.M.; Desalle, F.; Abramowicz, D.; Willems, F.; Leo, O.; Goldman, M.; Alegre, M.L. 1999: Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice Transplantation 68(5): 677-684
Yoshimura, N.; Lee, C.J.; Shiho, O.; Kita, M.; Imanishi, J.; Oka, T. 1995: Local immunosuppressive therapy with monoclonal anti-T-cell antibody on renal allograft survival in the rat. II. Phenotypic and functional assessment of spleen cells Transplantation Proceedings 27(1): 390-391
Hirsch, R.; Bluestone, J.A.; Bare, C.V.; Gress, R.E. 1991: Advantages of F(ab')2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice Transplantation Proceedings 23(1 Part 1): 270-271
Volk, H.D.; Brocke, S.; Osawa, H.; Diamantstein, T. 1986: Effects of in-vivo administration of a monoclonal antibody specific for the interleukin-2 receptor on the acute graft-versus-host reaction in mice Clinical and Experimental Immunology 66(1): 126-131
Wonigeit, K.; Nashan, B.; Schwinzer, R.; Schlitt, H.J.; Kurrle, R.; Racenberg, J.; Seiler, F.; Ringe, B.; Pichlmayr, R. 1989: Use of a monoclonal antibody against the T cell receptor for prophylactic immunosuppressive treatment after liver transplantation Transplantation Proceedings 21(1 Part 2): 2258-2259
Shinkura, H.; Imazeki, I.; Yamazaki, M.; Oda, Y.; Kotoh, M.; Mihara, M. 1998: In vivo blocking effects of a humanized antibody to human interleukin-6 receptor on interleukin-6 function in primates Anticancer Research 18(2a): 1217-1221
Cacalano, N.A.; Cleveland, W.L.; Erlanger, B.F. 1991: Characterization of a monoclonal anti-idiotypic antibody that mimics cyclosporine a in a single binding system Journal of Immunology 147(9): 3012-3017
Hiesse, C.; Lantz, O.; Kriaa, F.; Noury, J.; Fries, D.; Charpentier, B.; Bazin, H. 1991: Treatment with Lo-Tact-1, a monoclonal antibody to the interleukin-2 receptor, in kidney transplantation Presse Medicale 20(40): 2036-2038
Lácha, J.; Lehmann, M.; Chadimová, M.; Brock, J.; Havlícková, J. 1994: Effect of anti-CD4 monoclonal antibody and cyclosporine a or a combination of both on chronic rejection in the rat aortic allograft model Transplantation Proceedings 26(6): 3242-3243
Anderson, J.E.; Morris, R.E.; Blaschke, T.F. 1987: Pharmacodynamics of cyclosporine-ketoconazole interaction in mice. Combined therapy potentiates cyclosporine immunosuppression and toxicity Transplantation 43(4): 529-533
Ryffel, B.; Müller, S.; Foxwell, B. 1987: Cyclosporine a allows the expression of high affinity interleukin 2 binding sites on anti-T-cell antibody activated human T lymphocytes Transplantation Proceedings 19(1 Part 2): 1199-1201
Moroz, C.; Zaspin, E.; Shohat, B. 1996: An immunosuppressive effect of anti-p43 monoclonal antibody on human xenogeneic graft versus host response is mediated by CD8+ T cells Transplantation Proceedings 28(6): 3196-3198
Perosa, F.; Scudeletti, M.; Imro, M.A.; Dammacco, F.; Luccarelli, G.; Indiveri, F. 1997: Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases Clinical and Experimental Rheumatology 15(2): 201-210
Chen, Z.; Colon, I.; Ortiz, N.; Callister, M.; Dong, G.; Pegram, M.Y.; Arosarena, O.; Strome, S.; Nicholson, J.C.; Van Waes, C. 1998: Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines Cancer Research 58(16): 3668-3676
Vuist, W.M.; v Buitenen, F.; de Rie, M.A.; Hekman, A.; Rümke, P.; Melief, C.J. 1989: Potentiation by interleukin 2 of Burkitt's lymphoma therapy with anti-pan B (anti-CD19) monoclonal antibodies in a mouse xenotransplantation model Cancer Research 49(14): 3783-3788
Kelley, V.E.; Gaulton, G.N.; Hattori, M.; Ikegami, H.; Eisenbarth, G.; Strom, T.B. 1988: Anti-interleukin 2 receptor antibody suppresses murine diabetic insulitis and lupus nephritis Journal of Immunology 140(1): 59-61